At the next level, HERV-K-excited immune cells were collected from immunized mice and transferred to tumor-bearing mice (their murine colorectal cancer cells were genetically engineered to express the HERV-K Gag and Env antigens) [158]. The gene discussed is ERVW-1; the disease is neoplasm.